Iatrogenic hyperkalemic paralysis with electrocardiographic changes.
D001639:Bicarbonates / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004562:Electrocardiography; D005665:Furosemide / Q000009:adverse effects / Q000627:therapeutic use; D005942:Gluconates / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D007049:Iatrogenic Disease; D007328:Insulin / Q000627:therapeutic use; D007866:Leg; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010243:Paralysis / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D011188:Potassium / Q000009:adverse effects; D011191:Potassium Deficiency / Q000139:chemically induced / Q000150:complications; D012964:Sodium; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use
D001639:Bicarbonates; D005942:Gluconates; D007328:Insulin; D013148:Spironolactone; D005665:Furosemide; D012964:Sodium; D005947:Glucose; D011188:Potassium; D002118:Calcium